Skip to content

Regional and remote populations

Print as a PDF

Overview

  • Regional and remote populations differ from urban populations in having less access to medical care. Potential barriers include regional and remote health professionals knowing patients in a social context, or being locums and having little opportunity to build a relationship with patients.
  • Gaylesbian, bisexual, transgender and intersex (GLBTI) communities may be less visible in rural and remote areas and people may be reluctant to identify as GLBTI.
  • Aboriginal and Torres Strait Islander people represent a higher proportion of the population in many remote areas.
  • Due to less frequent attendance consider opportunistic sexually transmitted infection (STI) testing at every clinical encounter.

  • Regular annual STI and BBV testing is recommended for people 15-35 yo in this population, as per the Standard Asymptomatic Check-up guideline. More frequent testing (6-monthly) is recommended in many remote communities with higher prevalence of STIs
  • More frequent testing (6 monthly) is recommended in many remote communities with higher prevalence of STIs.
  • Trichomonas is more prevalent in regional and remote areas, and people should be tested according to local guidelines.
  • Higher rates of syphilis occur in regional and remote areas. Clinicians should have a low threshold for testing in people with possible symptoms of syphilis.
  • Congenital syphilis is a serious adverse event resulting from untreated syphilis in pregnancy. It can be prevented by appropriate testing and treatment for people who are pregnant or planning a pregnancy. Additional testing in pregnancy is required, refer to the Pregnancy Care Guidelines.
  • In remote areas, check for donovanosis with nucleic acid amplification test (NAAT) in anyone with an ano-genital ulcer.
  • Confirm hepatitis B status and discuss vaccination if not immune. Refer to the Australian Immunisation Handbook for guidance. Some, but not all, indications for vaccination are funded by the National Immunisation Program (NIP).
  • Testing for hepatitis C virus (HCV) should be done only if there is a history of injecting drug use, current HIV pre-exposure prophylaxis (PrEP) use, anal sex with a partner with HCV infection, incarceration, non-professional tattoos or body piercings or receipt of organs or blood products before 1990.
  • A sexual health check is an ideal time to discuss cervical cancer screening status and offer to organise CST if due.

Clinical indicators for testing

Special considerations

If test results are positive, refer to relevant STI management section:

Even if all test results are negative, use the opportunity to:

  • Ensure follow-up to investigate alternative causes of any symptoms.
  • Educate about condom use, contraception, HIV PrEP/PEP, safe injecting practices, consent, CST and vaccinations for HAV, HBV and HPV as indicated.
  • Discuss and activate reminders for regular testing according to risk, especially if the person’s lifestyle indicates the need for more frequent screening.

  • 100% young people (< 30-year old) in regional and remote areas are offered an asymptomatic STI test annually.

Specimen collection guidance

Clinician collected | Self-collection

Our Supporters

  • ASRHA
  • RACP
  • ASHHNA
  • Family Planning Alliance Australia
  • RACGP
  • MSI Australia
  • AusPATH
  • Australian College of Nurse Practitioners
  • Scarlet Alliance, Australian Sex Workers Association